Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years.

Möller B, Aletaha D, Andor M, Atkinson A, Aubry-Rozier B, Brulhart L, Dan D, Finckh A, Grobéty V, Mandl P, Micheroli R, Nissen MJ, Nydegger AM, Scherer A, Tamborrini G, Ziswiler HR, Zufferey P.

Rheumatology (Oxford). 2019 Oct 19. pii: kez460. doi: 10.1093/rheumatology/kez460. [Epub ahead of print]

2.

Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.

Gonzalez-Rodriguez E, Aubry-Rozier B, Stoll D, Zaman K, Lamy O.

Breast Cancer Res Treat. 2019 Oct 9. doi: 10.1007/s10549-019-05458-8. [Epub ahead of print]

PMID:
31598815
3.

Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.

Shevroja E, Aubry-Rozier B, Hans G, Rodriguez EG, Stoll D, Lamy O, Hans D.

J Bone Miner Res. 2019 Dec;34(12):2229-2237. doi: 10.1002/jbmr.3851. Epub 2019 Oct 25.

PMID:
31419331
4.

Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et al.

Gonzalez-Rodriguez E, Aubry-Rozier B, Stoll D, Lamy O.

Arthritis Rheumatol. 2019 Oct;71(10):1770-1771. doi: 10.1002/art.41016. Epub 2019 Aug 29. No abstract available.

PMID:
31215777
5.

Denosumab in early-stage breast cancer.

Gonzalez Rodriguez E, Aubry-Rozier B, Stoll D, Lamy O.

Lancet Oncol. 2019 May;20(5):e233. doi: 10.1016/S1470-2045(19)30181-0. No abstract available.

PMID:
31044710
6.

[How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]

Gonzalez Rodriguez E, Lamy O, Aubry-Rozier B, Stoll D, Uebelhart B.

Rev Med Suisse. 2019 Apr 17;15(647):831-835. French.

PMID:
30994986
7.

[What can we do at the discovery of an osteroporotic vertebral fracture ?]

Brulhart D, Stoll D, Gonzalez Rodriguez E, Aubry-Rozier B.

Rev Med Suisse. 2019 Apr 17;15(647):815-820. French.

PMID:
30994983
8.

Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT).

Caparbo VF, Furlam P, Saad CGS, Alvarenga JC, Aubry-Rozier B, Hans D, de Brum-Fernandes AJ, Pereira RMR.

Bone. 2019 May;122:8-13. doi: 10.1016/j.bone.2019.01.024. Epub 2019 Jan 29.

PMID:
30708186
9.

Stopping Denosumab.

Lamy O, Stoll D, Aubry-Rozier B, Rodriguez EG.

Curr Osteoporos Rep. 2019 Feb;17(1):8-15. doi: 10.1007/s11914-019-00502-4. Review.

PMID:
30659428
10.

Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.

Lamy O, Fernández-Fernández E, Monjo-Henry I, Stoll D, Aubry-Rozier B, Benavent-Núñez D, Aguado P, Gonzalez-Rodriguez E.

Osteoporos Int. 2019 May;30(5):1111-1115. doi: 10.1007/s00198-018-04820-8. Epub 2019 Jan 6.

PMID:
30613866
11.

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.

Biver E, Calmy A, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Ferrari S, Frey D, Kressig RW, Lamy O, Lippuner K, Suhm N, Meier C.

Osteoporos Int. 2019 May;30(5):1125-1135. doi: 10.1007/s00198-018-4794-0. Epub 2019 Jan 2.

PMID:
30603840
12.

Cohort Profile: The OsteoLaus study.

Shevroja E, Marques-Vidal P, Aubry-Rozier B, Hans G, Rivadeneira F, Lamy O, Hans D.

Int J Epidemiol. 2019 Aug 1;48(4):1046-1047g. doi: 10.1093/ije/dyy276. No abstract available.

PMID:
30590566
13.

Hepatosplenomegaly, pneumopathy, bone changes and fronto-temporal dementia: Niemann-Pick type B and SQSTM1-associated Paget's disease in the same individual.

Voinea C, Gonzalez Rodriguez E, Beigelman-Aubry C, Leroy V, Aubry-Rozier B, Campos-Xavier B, Ballhausen D, Lazor R, Barbey F, Bonafé L, Superti-Furga A, Tran C.

J Bone Miner Metab. 2019 Mar;37(2):378-383. doi: 10.1007/s00774-018-0932-1. Epub 2018 Jun 14.

PMID:
29948344
14.

[Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]

Lamy O, Gonzalez Rodriguez E, Stoll D, Aubry-Rozier B, Livio F.

Praxis (Bern 1994). 2018 Jun;107(12):649-654. doi: 10.1024/1661-8157/a002997. Review. French.

PMID:
29871576
15.

Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.

Aubry-Rozier B, Stoll D, Gonzalez Rodriguez E, Hans D, Prudent V, Seuret A, Farron A, Lamy O.

Swiss Med Wkly. 2018 Jan 4;148:w14579. doi: 10.4414/smw.2018.14579. eCollection 2018.

16.

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women.

Lamy O, Aubry-Rozier B, Gonzalez-Rodriguez E.

Ann Intern Med. 2017 Dec 19;167(12):900-901. doi: 10.7326/L17-0485. No abstract available.

PMID:
29255866
17.

[Rare vascular diseases, building dedicated multidisciplinary specialized center].

Krieger C, Baud D, Bouchardy J, Christen-Zaech S, De Buys A, Deglise S, El Ezzi O, Fresa M, Hofer M, Hohl D, Kirsch M, Lazor R, Michel P, Monney P, Munier F, Qanadli SD, Raffoul W, Aubry Rozier B, Saucy F, Schoepfer A, Saliou G, Sekarski N, Superti-Furga A, Wuerzner G, Wasserfallen JB, Mazzolai L.

Rev Med Suisse. 2017 Dec 6;13(586):2109-2115. French.

PMID:
29211369
18.

Administration de fer, hypophosphatémie et ostéomalacie.

Aubry-Rozier B, Stoll D, Rodriguez Gonzalez E.

Rev Med Suisse. 2017 Sep 27;13(576):1665. French. No abstract available.

PMID:
28953338
19.

Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.

Meier C, Uebelhart B, Aubry-Rozier B, Birkhäuser M, Bischoff-Ferrari HA, Frey D, Kressig RW, Lamy O, Lippuner K, Stute P, Suhm N, Ferrari S.

Swiss Med Wkly. 2017 Aug 16;147:w14484. doi: 10.4414/smw.2017.14484. eCollection 2017.

20.

Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.

Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Zillikens MC.

Bone. 2017 Dec;105:11-17. doi: 10.1016/j.bone.2017.08.003. Epub 2017 Aug 5. Review.

PMID:
28789921
21.

[Denosumab in clinical practice : beware before, during and after].

Lamy O, Gonzalez-Rodriguez E, Stoll D, Aubry-Rozier B.

Rev Med Suisse. 2017 Apr 19;13(559):863-866. French.

PMID:
28727345
22.

[Phosphocalcic anomalies and bone fragility keys for the general practitioner].

Aubry-Rozier B, Stoll D, Gonzalez-Rodriguez E.

Rev Med Suisse. 2017 Apr 19;13(559):838-843. French.

PMID:
28727340
23.

[Drugs induced osteopathies].

Aubry-Rozier B.

Rev Med Suisse. 2017 Mar 8;13(553):549-553. Review. French.

PMID:
28718587
24.

Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.

Lamy O, Gonzalez-Rodriguez E, Aubry-Rozier B.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):2112. doi: 10.1210/jc.2017-00096. No abstract available.

PMID:
28586456
25.

High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study.

Gonzalez Rodriguez E, Lamy O, Stoll D, Metzger M, Preisig M, Kuehner C, Vollenweider P, Marques-Vidal P, Waeber G, Aubry-Rozier B, Hans D.

J Clin Endocrinol Metab. 2017 Jul 1;102(7):2628-2636. doi: 10.1210/jc.2016-3804.

PMID:
28379565
26.

Response to the Letter by Trovas.

Lamy O, Gonzalez-Rodriguez E, Aubry-Rozier B.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):1087. doi: 10.1210/jc.2016-3880. No abstract available.

PMID:
28359105
27.

Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases.

Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O.

J Bone Miner Res. 2017 Jun;32(6):1291-1296. doi: 10.1002/jbmr.3110. Epub 2017 Mar 13. Review.

28.

The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.

Padlina I, Gonzalez-Rodriguez E, Hans D, Metzger M, Stoll D, Aubry-Rozier B, Lamy O.

Osteoporos Int. 2017 Mar;28(3):909-915. doi: 10.1007/s00198-016-3829-7. Epub 2016 Nov 30.

PMID:
27900426
29.

Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: 9 Clinical Cases Report.

Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):354-358. doi: 10.1210/jc.2016-3170.

PMID:
27732330
30.

Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.

Su Y, Leung J, Hans D, Aubry-Rozier B, Kwok T.

Osteoporos Int. 2017 Jan;28(1):151-160. doi: 10.1007/s00198-016-3785-2. Epub 2016 Oct 11.

PMID:
27725999
31.

Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.

Aubry-Rozier B, Fabreguet I, Iglesias K, Lamy O, Hans D.

Osteoporos Int. 2017 Feb;28(2):523-527. doi: 10.1007/s00198-016-3757-6. Epub 2016 Sep 2.

PMID:
27589975
32.

Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis.

Wildberger L, Boyadzhieva V, Hans D, Stoilov N, Rashkov R, Aubry-Rozier B.

Joint Bone Spine. 2017 Jul;84(4):463-466. doi: 10.1016/j.jbspin.2016.05.015. Epub 2016 Jul 21.

PMID:
27450198
33.

Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.

Bregou Bourgeois A, Aubry-Rozier B, Bonafé L, Laurent-Applegate L, Pioletti DP, Zambelli PY.

Swiss Med Wkly. 2016 Jun 20;146:w14322. doi: 10.4414/smw.2016.14322. eCollection 2016.

34.

Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.

Aubry-Rozier B, Gonzalez-Rodriguez E, Stoll D, Lamy O.

Osteoporos Int. 2016 May;27(5):1923-5. doi: 10.1007/s00198-015-3380-y. Epub 2015 Oct 28.

PMID:
26510845
35.

Osseous Sarcoidosis Revealed by a Pathologic Fracture and Successfully Treated With Methotrexate and Prednisone.

Ahmanna-Chakir F, Becce F, Aubry-Rozier B.

Arthritis Rheumatol. 2016 Feb;68(2):472. doi: 10.1002/art.39454. No abstract available.

36.

Potential blindness in children of patients with hereditary bone disease.

Kheir V, Munier FL, Aubry-Rozier B, Schorderet DF.

Osteoporos Int. 2016 Feb;27(2):841-4. doi: 10.1007/s00198-015-3245-4. Epub 2015 Aug 5.

PMID:
26243358
37.

[News in osteogenesis imperfecta: from research to clinical management].

Aubry-Rozier B, Unger S, Bregou A, Freymond Morisod M, Vaswani A, Scheider P, Bonafé L.

Rev Med Suisse. 2015 Mar 18;11(466):657-8, 660-2. French.

PMID:
25962227
38.

AA amyloidosis treated with tocilizumab: case series and updated literature review.

Courties A, Grateau G, Philippe P, Flipo RM, Astudillo L, Aubry-Rozier B, Fabreguet I, Fahd W, Fain O, Guggenbuhl P, Hachulla E, Papo T, Richez C, Sibilia J, Morel J, Berenbaum F, Sellam J; Club Rhumatismes Inflammation and the REGATE Registry.

Amyloid. 2015;22(2):84-92. doi: 10.3109/13506129.2014.1002031. Epub 2015 Jan 14. Review.

PMID:
25585627
39.

Reproducibility of Vertebral Fracture Assessment Readings From Dual-energy X-ray Absorptiometry in Both a Population-based and Clinical Cohort: Cohen's and Uniform Kappa.

Aubry-Rozier B, Chapurlat R, Duboeuf F, Iglesias K, Krieg MA, Lamy O, Burnand B, Hans D.

J Clin Densitom. 2015 Apr-Jun;18(2):233-8. doi: 10.1016/j.jocd.2014.09.001. Epub 2014 Nov 13.

PMID:
25439454
40.

Spine bone texture assessed by trabecular bone score (TBS) to evaluate bone health in thalassemia major.

Baldini M, Ulivieri FM, Forti S, Serafino S, Seghezzi S, Marcon A, Giarda F, Messina C, Cassinerio E, Aubry-Rozier B, Hans D, Cappellini MD.

Calcif Tissue Int. 2014 Dec;95(6):540-6. doi: 10.1007/s00223-014-9919-7. Epub 2014 Oct 28.

PMID:
25348077
41.

[Atypical fractures of the femur: apropos of 3 clinical cases].

Sanduloviciu M, Stoll D, Lamy O, Krieg MA, Aubry-Rozier B.

Praxis (Bern 1994). 2014 Aug 6;103(16):939-44. doi: 10.1024/1661-8157/a001742. French.

PMID:
25097162
42.

Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.

Zufferey P, Ghosn J, Becce F, Ciurea A, Aubry-Rozier B, Finckh A, So AK.

Rheumatol Int. 2015 Feb;35(2):295-302. doi: 10.1007/s00296-014-3094-z. Epub 2014 Jul 29.

PMID:
25070142
43.

Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.

Leslie WD, Aubry-Rozier B, Lix LM, Morin SN, Majumdar SR, Hans D.

Bone. 2014 Oct;67:10-4. doi: 10.1016/j.bone.2014.06.034. Epub 2014 Jul 2.

PMID:
24998455
44.

Vertebral microarchitecture and fragility fracture in men: a TBS study.

Leib E, Winzenrieth R, Aubry-Rozier B, Hans D.

Bone. 2014 May;62:51-5. doi: 10.1016/j.bone.2013.12.015. Epub 2013 Dec 19.

PMID:
24361639
45.

Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study.

Stoll D, Lamy O, Hans D, Zufferey P, So A, Krieg MA, Aubry-Rozier B.

Swiss Med Wkly. 2013 Dec 6;143:w13891. doi: 10.4414/smw.2013.13891. eCollection 2013.

46.

Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures.

Lamy O, Uebelhart B, Aubry-Rozier B.

Osteoporos Int. 2014 Mar;25(3):807-19. doi: 10.1007/s00198-013-2574-4. Epub 2013 Nov 22. Review.

PMID:
24264371
47.

Morphometric vertebral assessments via the use of dual X-ray absorptiometry for the evaluation of radiographic damage in ankylosing spondylitis: a pilot study.

Aubry-Rozier B, Hans D, Krieg MA, Lamy O, Dudler J.

J Clin Densitom. 2014 Jan-Mar;17(1):190-4. doi: 10.1016/j.jocd.2013.09.004. Epub 2013 Oct 22.

PMID:
24161790
48.

Clinical images: enchondromatosis (Ollier disease).

Cerny M, Rudiger HA, Aubry-Rozier B, Dugert E, Becce F.

Arthritis Rheum. 2013 Nov;65(11):2886. doi: 10.1002/art.38115. No abstract available.

49.

Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women.

Krueger D, Fidler E, Libber J, Aubry-Rozier B, Hans D, Binkley N.

J Clin Densitom. 2014 Jan-Mar;17(1):60-5. doi: 10.1016/j.jocd.2013.05.001. Epub 2013 Jun 13.

PMID:
23769698
50.

[Connective tissue diseases: news in therapy, role of biologics agents].

Aubry-Rozier B, Fabreguet I.

Rev Med Suisse. 2013 Mar 13;9(377):556, 558-60. French.

PMID:
23534242

Supplemental Content

Loading ...
Support Center